Angiography and Vascular Interventions

Angiography and vascular interventions represent a major domain within interventional radiology, encompassing both diagnostic imaging of blood vessels and catheter-based procedures that treat vascular disease directly. These techniques allow radiologists to visualize arterial and venous anatomy with precision and, in the same procedural setting, deliver targeted therapy without open surgery. The scope covers conditions ranging from peripheral arterial occlusion to intracranial aneurysm, making vascular intervention one of the broadest subspecialties in modern radiology practice.

Definition and scope

Angiography is the fluoroscopic or cross-sectional imaging of blood vessels achieved by injecting iodinated contrast material into the vascular system and capturing the resulting opacification with X-ray, CT, or MRI detectors. When performed through a catheter advanced into a specific vessel, the technique is called catheter-based or conventional angiography; when performed non-invasively using CT or MRI scanners, it is called CT angiography (CTA) or MR angiography (MRA).

Vascular interventions extend beyond imaging: the same catheter access used for diagnostic angiography enables delivery of devices — balloons, stents, embolic agents, thrombolytics — directly to the diseased vessel segment. The American College of Radiology (ACR) and the Society of Interventional Radiology (SIR) jointly publish practice parameters that define the standard of care for these procedures, distinguishing diagnostic angiography (ACR Practice Parameter for Diagnostic Arteriography) from therapeutic vascular interventions governed by separate SIR guidelines.

Regulatory oversight in the United States places catheter-based vascular procedures under the Centers for Medicare and Medicaid Services (CMS) hospital Conditions of Participation, which require physician credentialing, informed consent documentation, and post-procedure monitoring protocols. The broader regulatory context for radiology — including FDA device approval for stents and embolic agents used in these procedures — shapes how interventional suites operate at every accredited facility.

How it works

Catheter-based angiography follows a structured sequence:

  1. Vascular access: A hollow introducer sheath (typically 4–6 French in diameter, where 1 French equals 0.33 mm) is placed percutaneously into the femoral, radial, brachial, or jugular vein or artery under ultrasound guidance.
  2. Catheter navigation: Using fluoroscopic guidance, the interventional radiologist advances a wire and catheter through the vascular tree to the target vessel. Road-mapping software overlays a previously acquired contrast image onto the live fluoroscopy feed.
  3. Contrast injection and imaging: Iodinated contrast is injected at a controlled rate; digital subtraction angiography (DSA) removes background bone and soft-tissue density to isolate vessel opacification. Frame rates typically range from 2 to 6 frames per second for most peripheral studies, rising to 15–30 frames per second for coronary or intracranial work.
  4. Intervention delivery: Balloons, stents, coils, liquid embolic agents, or thrombolytic drugs are deployed through the catheter at the disease site.
  5. Closure and monitoring: Sheath removal is followed by manual compression, a closure device, or a vascular plug; patients undergo hemostasis observation for 2–6 hours depending on access site and anticoagulation status.

Radiation dose is a primary safety consideration. The ACR and the National Council on Radiation Protection and Measurements (NCRP) publish guidance (NCRP Report No. 168) on fluoroscopy time and cumulative air kerma thresholds — 3 gray (Gy) to the skin is a commonly cited trigger level for post-procedural dose tracking, though actual tissue injury thresholds vary with beam geometry. Contrast nephropathy risk is managed per ACR Manual on Contrast Media guidance, which stratifies patients by estimated glomerular filtration rate (eGFR) and identifies eGFR below 30 mL/min/1.73 m² as the highest-risk category (ACR Manual on Contrast Media).

Common scenarios

Vascular angiography and intervention is applied across a broad range of clinical presentations:

The full spectrum of radiology subspecialties available at a given institution determines which of these services are performed in-house versus referred to a quaternary center.

Decision boundaries

Not all vascular disease is best managed through catheter-based intervention, and radiological, anatomical, and patient-level factors define the decision space.

Diagnostic CTA/MRA versus conventional angiography: Non-invasive CTA and MRA have largely replaced diagnostic-only conventional angiography for most vascular territories. Conventional angiography is reserved for cases where intervention will likely follow immediately, where non-invasive imaging is technically limited (e.g., severe artifact from metallic implants), or where hemodynamic measurement (pressure gradients) is required.

Endovascular versus surgical repair: Anatomical criteria drive selection. For aortic aneurysm, the Instructions for Use (IFU) accompanying each FDA-cleared stent-graft device specify minimum neck length (typically 15 mm), maximum neck angulation, and iliac artery diameter requirements. Patients outside IFU are evaluated for open repair by vascular surgery.

Contrast considerations: Gadolinium-based contrast agents used in MRA carry a distinct risk profile from iodinated agents. In patients with stage 4–5 chronic kidney disease, nephrogenic systemic fibrosis (NSF) risk informs gadolinium agent selection (ACR Manual on Contrast Media). Carbon dioxide (CO₂) gas can serve as an alternative contrast agent for below-diaphragm angiography in patients with severe iodine contrast allergy or renal insufficiency.

Radiation-sensitive populations: Pediatric patients and pregnant patients require individualized dose management. The ACR and radiologyauthority.com both reflect consensus that ALARA (As Low As Reasonably Achievable) principles, formalized in NCRP Report No. 168, apply with particular force in these groups. Pregnancy and angiography decisions intersect with the guidance detailed across imaging during pregnancy resources.

The appropriate use of vascular intervention is governed jointly by procedural guidelines from the SIR, ACR appropriateness criteria, and device-specific FDA labeling — with institutional credentialing committees serving as the local enforcement mechanism for each.

References

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)